SCHEMBL29567116

SCHEMBL29567116

CCc1c(Oc2ccc(N3CCNCC3)cc2)nc(NS(=O)(=O)c2cnn(C)c2)nc1-c1cccc(C)c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ BTK Q06187 1/20 0.36
▸ TNK2 Q07912 1/20 0.36
▸ NOD2 Q9HC29 10/20 0.35
▸ RIPK2 O43353 8/20 0.35
▸ ACVR1 Q04771 8/20 0.35
▸ EGFR P00533 1/20 0.35
▸ HTR6 P50406 1/20 0.34
▸ ALOX12 P18054 1/20 0.33
▸ GUSB P08236 3/20 0.32
▸ CCNB2 O95067 1/20 0.32
▸ CCNE2 O96020 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310024 1.00 LCK (0.36) LCKJAK3BTKTNK2NOD2
SCHEMBL29567089 0.94 HTR6 (0.37) LCKJAK3BTKTNK2NOD2
SCHEMBL24310067 0.94 HTR6 (0.37) LCKJAK3BTKTNK2NOD2
SCHEMBL26811450 0.93 GUSB (0.36) LCKJAK3BTKTNK2NOD2
SCHEMBL29567543 0.92 LCK (0.37) LCKJAK3BTKTNK2NOD2
SCHEMBL24310035 0.92 LCK (0.37) LCKJAK3BTKTNK2NOD2
SCHEMBL24309488 0.89 GUSB (0.37) NOD2RIPK2ACVR1EGFRHTR6
SCHEMBL29566605 0.89 GUSB (0.37) NOD2RIPK2ACVR1EGFRHTR6
SCHEMBL24310104 0.88 NOD2 (0.36) LCKJAK3BTKTNK2NOD2
SCHEMBL29566496 0.88 NOD2 (0.36) LCKJAK3BTKTNK2NOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback